Anterior skull base malignant neoplasms are rare, accounting for less than 1% of all malignancies and 3 to 5% of head and neck cancers. However, they differ in their presentation, prognosis, and histopathology. In addition, they are often diagnosed at an advanced metastatic stage of the disease. Due to its rarity and wide range of presentation, there is no consensus on staging systems and treatment algorithms for anterior skull base malignancies.
To get detailed insights into the “Treatment Strategies for Anterior Skull Base Malignancies,” join the proficient Head and Neck Surgical Oncologist, Dr. Yogesh Dokhe , in our exclusive webinar on 1 st October 2024 , 11:00 AM IST onwards. Stay Tuned Suggested readings The First-ever Vaccine for Glioblastoma Ponatinib Repurposed to Fight Aggressive Tumors LIGHT Therapy Helps Immune System Promote Anti-tumor Immunity in Glioma ##Disclaimer## The…
